ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · IEX Real-Time Price · USD
0.0761
-0.0059 (-7.20%)
At close: Jul 19, 2024, 4:00 PM
0.0779
+0.0018 (2.37%)
Pre-market: Jul 22, 2024, 7:18 AM EDT
ENDRA Life Sciences Market Cap
ENDRA Life Sciences has a market cap or net worth of $5.35 million as of July 22, 2024. Its market cap has decreased by -50.48% in one year.
Market Cap
5.35M
Enterprise Value
4.54M
1-Year Change
-50.48%
Ranking
Category
Stock Price
$0.08
Market Cap Chart
Since June 30, 2017, ENDRA Life Sciences's market cap has decreased from $15.20M to $5.35M, a decrease of -64.82%. That is a compound annual growth rate of -13.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 800.00K | -95.53% |
| Dec 29, 2023 | 17.90M | 38.76% |
| Dec 30, 2022 | 12.90M | -55.82% |
| Dec 31, 2021 | 29.20M | 55.32% |
| Dec 31, 2020 | 18.80M | 49.21% |
| Dec 31, 2019 | 12.60M | 55.56% |
| Dec 31, 2018 | 8.10M | -57.37% |
| Dec 29, 2017 | 19.00M | 25.00% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biomerica | 5.59M |
| FSD Pharma | 5.59M |
| Synaptogenix | 5.54M |
| TransCode Therapeutics | 5.49M |
| Lixte Biotechnology Holdings | 5.38M |
| BioCardia | 5.30M |
| Leafly Holdings | 5.25M |
| Clearmind Medicine | 5.20M |